Tenon Medical annual stock-based compensation
2021
2022
2023
2024
2025
Tenon Medical Stock-Based Compensation Growth & History (TNON)
Tenon Medical's stock-based compensation was $1.7M for fiscal 2025.
View full Tenon Medical company overviewTenon Medical annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.7M | −$2.2M | −56.02% |
| 2024 | 2024-12-31 | $3.8M | −$300,000 | −7.24% |
| 2023 | 2023-12-31 | $4.1M | $1.2M | +43.08% |
| 2022 | 2022-12-31 | $2.9M | $2.5M | +668.44% |
| 2021 | 2021-12-31 | $377,000 | — | — |
Tenon Medical quarterly stock-based compensation
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $412,000 | −$5,000 | −1.20% |
| Q1 2026 | 2026-03-31 | $331,000 | −$541,000 | −62.04% |
| Q4 2025 | 2025-12-31 | $344,000 | −$539,000 | −61.04% |
| Q3 2025 | 2025-09-30 | $58,000 | −$852,000 | −93.63% |
| Q2 2025 | 2025-06-30 | $417,000 | −$617,000 | −59.67% |
| Q1 2025 | 2025-03-31 | $872,000 | −$146,000 | −14.34% |
| Q4 2024 | 2024-12-31 | $883,000 | −$98,000 | −9.99% |
| Q3 2024 | 2024-09-30 | $910,000 | −$160,000 | −14.95% |
| Q2 2024 | 2024-06-30 | $1.0M | −$20,000 | −1.90% |
| Q1 2024 | 2024-03-31 | $1.0M | −$22,000 | −2.12% |
| Q4 2023 | 2023-12-31 | $981,000 | −$161,000 | −14.10% |
| Q3 2023 | 2023-09-30 | $1.1M | $36,000 | +3.48% |
| Q2 2023 | 2023-06-30 | $1.1M | $502,000 | +90.94% |
| Q1 2023 | 2023-03-31 | $1.0M | $871,000 | +515.38% |
| Q4 2022 | 2022-12-31 | $1.1M | $973,000 | +575.74% |
| Q3 2022 | 2022-09-30 | $1.0M | $891,000 | +623.08% |
| Q2 2022 | 2022-06-30 | $552,000 | $491,000 | +804.92% |
| Q1 2022 | 2022-03-31 | $169,000 | $165,000 | +4125.00% |
| Q4 2021 | 2021-12-31 | $169,000 | — | — |
| Q3 2021 | 2021-09-30 | $143,000 | — | — |
| Q2 2021 | 2021-06-30 | $61,000 | — | — |
| Q1 2021 | 2021-03-31 | $4,000 | — | — |
Tenon Medical stock-based compensation trends
Between the periods ended 2021-12-31 and 2025-12-31, Tenon Medical's stock-based compensation increased from $377,000 to $1.7M, a change of $1.3M. The latest reported quarter, Q2 2026, shows $412,000.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenon Medical source filings ↗